Observatoire des droits humains (anglais seulement)

The UK must invest in medicines – but not at any price

(Version anglaise seulement)

par Catia Nicodemo, Professor of Health Economics, Brunel University of London

The UK’s science minister, Sir Patrick Vallance, has sounded the alarm over the country’s declining investment in medicines. He warned that the NHS risks losing out on important treatments and the country could lose its place at the cutting edge of medical research if spending does not recover. It comes at a sensitive time – this year drugmakers including Merck and AstraZeneca have backtracked on plans to invest in the UK.

Vallance is correct…

Lire l'article complet